FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the compound 2,3,4-trimethoxy-N-(2,2,6,6-tetramethylpiperidin-4-ylidene)benzohydrazide hydrochloride.
EFFECT: connection as an antiserotonin cerebrovascular and anti-migraine agent, belongs to low-hazard substances (toxicity class 4), does not cause undesirable side effects, significantly exceeds tropane derivatives in terms of economic feasibility of synthesis.
1 cl, 11 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF PIPERIDINE DERIVATIVE WITH PICAMILONE, HAVING ANTISEROTONIN AND ANTI-ISCHEMIC ACTIVITY | 2023 |
|
RU2822877C1 |
ACYLHYDRAZONE (2,3,4-TRIMETHOXY-N'-(8-METHYL-8-AZABICYCLO[3.2.1.]OCTANE-3-YLIDENE) BENZOHYDRAZIDE HYDROCHLORIDE), HAVING ANTIMIGRAINE AND ANXIOLYTIC ACTIVITY | 2016 |
|
RU2699658C2 |
PHARMACEUTICAL COMPOSITION WITH ANTIMIGRAINE ACTION (VERSIONS) | 2008 |
|
RU2424803C2 |
DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
USE OF 3,4,5-TRIMETHOXY-N'(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YLIDENE)BENZOHYDRAZIDE HYDROCHLORIDE AS AN ANXIOLYTIC AGENT | 2016 |
|
RU2691454C2 |
SUCCINIC ACID ESTERS OF 5-HYDROXYADAMANTAN-2-ONE, IMPROVING BLOOD SUPPLY TO ISCHEMIC BRAIN | 2017 |
|
RU2658833C1 |
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
ANTIAGGREGANT | 2005 |
|
RU2353363C2 |
DRUG WITH ANTIHYPOXIC, ANTIAMNESTIC AND NEUROPROTECTIVE ACTIVITY | 2020 |
|
RU2750418C1 |
MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
Authors
Dates
2023-09-19—Published
2022-12-21—Filed